Welcome to our dedicated page for Exponent news (Ticker: EXPO), a resource for investors and traders seeking the latest updates and insights on Exponent stock.
Exponent Inc reports developments in science and engineering consulting, including financial results, client demand across its two operating segments, and capital-return actions. Its engineering and other scientific work includes failure analysis, dispute-related consulting, user research for consumer electronics, utility risk management, asset integrity, transportation, energy, construction, life sciences, and medical device support.
The company’s environmental and health segment is tied to chemical regulation, food safety, ecological and biological sciences, and environmental consulting. Recurring updates also cover quarterly dividends, share repurchase authorizations, conference calls, executive appointments, board matters, and governance changes.
Exponent (Nasdaq: EXPO) reported second quarter 2026 revenues of $171.6 million, up 21% year over year, with revenues before reimbursements rising 12% to $148.9 million. Net income was $29.4 million, or $0.60 per diluted share, versus $26.6 million and $0.52 a year earlier. EBITDA increased to $42.7 million, representing a margin of 28.7% of revenues before reimbursements.
For the first half of 2026, revenues before reimbursements grew 11% to $300.7 million and net income reached $59.0 million ($1.19 diluted EPS). According to Exponent, it paid $31.3 million in dividends, repurchased $146.1 million of stock, declared a $0.31 quarterly dividend, and added $50 million to its repurchase authorization. The company raised 2026 guidance, now expecting revenues before reimbursements to grow 9%–10% and EBITDA margins of 27.8%–28.1%.
Exponent (Nasdaq: EXPO) announced that its Board of Directors declared a Q3 2026 quarterly cash dividend of $0.31 per share, payable on September 18, 2026 to stockholders of record on September 4, 2026. The Board also increased share repurchase authorization by $50 million, aligning with the company’s stated focus on returning capital to shareholders while investing for long-term growth.
Exponent (Nasdaq:EXPO) will release Second Quarter fiscal 2026 results for the period ended July 3, 2026, after market close on Thursday, July 30, 2026. Management will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss business and financial results.
Investors can access the live and archived webcast via the Investor Relations section of Exponent’s website and use the provided dial-in numbers or replay line and passcode through August 6, 2026.
Exponent (Nasdaq: EXPO) will host an Investor Day at its Phoenix Test & Engineering Center on September 29, 2026, at 8:30 a.m. PT. The half-day event will feature leadership presentations, facility tours, and live demonstrations of advanced testing, failure analysis, and multidisciplinary engineering capabilities.
Exponent (Nasdaq:EXPO) announced that CEO Dr. Catherine Corrigan, President John Pye, EVP Richard Schlenker, and CFO Eric Anderson will join a fireside chat at the Wells Fargo 16th Annual Industrials & Materials Conference.
The session takes place on June 9, 2026, at 12:00 p.m. ET, with a live webcast and archived replay available on Exponent’s investor relations website.
Exponent (Nasdaq: EXPO) reported Q1 FY2026 results for the period ended April 3, 2026. Total revenues rose 14% to $166.3M and revenues before reimbursements rose 10% to $151.8M. Net income was $29.6M, or $0.59 diluted per share.
EBITDA was $43.1M (28.4% of net revenues). The company paid $16.6M in dividends, repurchased $78.8M of stock, ended the quarter with $118.6M cash, raised its buyback authorization by $50M, and maintained full-year guidance (high-single-digit revenue growth; EBITDA 27.6%–28.1% of revenues before reimbursements).
Exponent (Nasdaq: EXPO) declared a quarterly cash dividend of $0.31 per share, payable on June 18, 2026 to shareholders of record as of June 5, 2026. The company reaffirmed its quarterly cadence (March, June, September, December).
In addition, the Board increased the share repurchase authorization by $50 million, supplementing $17.7 million available as of April 3, 2026. Management cited profitability and a strong balance sheet as support for continued capital returns.
Exponent (Nasdaq: EXPO) will report First Quarter fiscal 2026 results for the period ended April 3, 2026 after market close on Thursday, April 30, 2026.
Dr. Catherine Corrigan, CEO and President, and Richard Schlenker, EVP and CFO, will host a conference call and webcast at 4:30 p.m. ET / 1:30 p.m. PT. Live dial-in numbers, a live and archived webcast, and a telephonic replay through May 7, 2026 are provided for investors.
Exponent (Nasdaq:EXPO) announced leadership changes effective May 1, 2026 and at the Annual Meeting on June 4, 2026: John Pye named President, Eric Anderson named Chief Financial Officer, Richard Schlenker to remain Executive VP and stand for election to the Board, and Karen Richardson to become Board Chair upon Paul Johnston’s retirement.
All appointments are internal promotions reflecting continuity in technical and financial leadership.
Exponent (Nasdaq: EXPO) reported Q4 and fiscal 2025 results: Q4 revenue $147.4M (+7.8% vs. prior-year quarter) and FY revenue $582.0M (+4.2% vs. prior year). Q4 net income was $24.8M ($0.49 diluted EPS); FY net income was $106.0M ($2.07 diluted EPS). EBITDA for FY 2025 was $148.1M (27.6% of revenues before reimbursements). The board raised the quarterly cash dividend to $0.31 payable March 20, 2026, and the company repurchased $97.8M of common stock during the year.
Management expects high-single-digit revenue growth for Q1 and full-year 2026 and FY EBITDA margin around 27.6%–28.1% of revenues before reimbursements.